Retifanlimab (Anti-PDCD1 / PD-1 / CD279)Retifanlimab (Anti-PDCD1 / PD-1 / CD279)
Move your mouse over image or click to enlarge

Retifanlimab (Anti-PDCD1 / PD-1 / CD279)

Retifanlimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting programmed cell death protein 1 (anti-PD-1). It can be used for the research of gastroesophageal adenocarcinoma (GEA). MW :145.64 KD.
Cat# Size Price Qty Buy
A3037-1mg*25 1mg*25
£2,432.00
A3037-1mg*5 1mg*5
£794.00
A3037-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3037

Related Documents